PTGS2 and prostate cancer: Similarly, Hsu et al. [113] found that inhibition of Akt phosphorylation by celecoxib in prostate cancer models (LNCaP and PC3 cell lines which express constitutively COX-2) led to apoptosis, but in this case without affecting Bcl-2 level.